Literature DB >> 10869392

Isoprostanes, novel eicosanoids that produce nociception and sensitize rat sensory neurons.

A R Evans1, H Junger, M D Southall, G D Nicol, L S Sorkin, J T Broome, T W Bailey, M R Vasko.   

Abstract

Isoprostanes are a novel class of eicosanoids primarily formed by peroxidation of arachidonic acid. Because of their potential as inflammatory and/or hyperalgesic agents whose formation is largely independent of cyclooxygenases, we examined whether 8-iso prostaglandin E(2) (8-iso PGE(2)) or 8-iso prostaglandin F(2alpha) (8-iso PGF(2alpha)) reduces mechanical and thermal withdrawal threshold in rats, and whether they sensitize rat sensory neurons. Injection of 1 microg of 8-iso PGE(2) (in 2.5 microl) into the hindpaw of rats significantly reduced mechanical and thermal withdrawal thresholds, whereas 1 microg of 8-iso PGF(2alpha) elicited a transient decrease in only the mechanical withdrawal threshold. Both isoprostanes enhanced the firing of C-nociceptors in a concentration-dependent manner when injected into peripheral receptive fields. Exposing sensory neurons grown in culture to 1 microM 8-iso PGE(2) or 8-iso PGF(2alpha) augmented the number of action potentials elicited by a ramp of depolarizing current. In contrast, 8-iso PGE(2) but not 8-iso PGF(2alpha) enhanced the release of substance P- and calcitonin gene-related peptide-like immunoreactivity from isolated sensory neurons. Ten micromolar 8-iso PGE(2) stimulated peptide release directly, whereas treatment with 1 microM 8-iso PGE(2) augmented the release evoked by either bradykinin or capsaicin. Pretreating neuronal cultures with the nonsteroidal anti-inflammatory drug ketorolac did not alter the sensitizing action of 8-iso PGE(2) on peptide release, suggesting that this action of the isoprostane was not secondary to the production of prostaglandins via the cyclooxygenase pathway. These data support the notion that isoprostanes are an important class of inflammatory mediators that augment nociception.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869392

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

Review 1.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  Antioxidant supplementation reduces endometriosis-related pelvic pain in humans.

Authors:  Nalini Santanam; Nino Kavtaradze; Ana Murphy; Celia Dominguez; Sampath Parthasarathy
Journal:  Transl Res       Date:  2012-05-31       Impact factor: 7.012

3.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

4.  Pharmacokinetic-pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in rats.

Authors:  D A Vásquez-Bahena; U E Salazar-Morales; M I Ortiz; G Castañeda-Hernández; Iñaki F Trocóniz
Journal:  Br J Pharmacol       Date:  2009-12-02       Impact factor: 8.739

5.  Tempol attenuates the exercise pressor reflex independently of neutralizing reactive oxygen species in femoral artery ligated rats.

Authors:  Jennifer L McCord; Hirotsugu Tsuchimochi; Katsuya Yamauchi; Anna Leal; Marc P Kaufman
Journal:  J Appl Physiol (1985)       Date:  2011-07-07

Review 6.  Pathogenesis of degenerative temporomandibular joint arthritides.

Authors:  Stephen B Milam
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

7.  Biological characteristics of tracheal smooth muscle cells regulated by NK-1R in asthmatic rat with airway remodeling.

Authors:  Bing Wei; Yali Liu; Xiaozhe Yue; Yinping Li; Yunxiao Shang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  Involvement of platelet-activating factor in ultraviolet B-induced hyperalgesia.

Authors:  Qiwei Zhang; Leslie A Sitzman; Mohammad Al-Hassani; Shanbao Cai; Karen E Pollok; Jeffrey B Travers; Cynthia M Hingtgen
Journal:  J Invest Dermatol       Date:  2008-06-26       Impact factor: 8.551

9.  Oxidative stress in fibromyalgia and its relationship to symptoms.

Authors:  Cecilia P Chung; Dina Titova; Annette Oeser; Margaret Randels; Ingrid Avalos; Ginger L Milne; Jason D Morrow; C Michael Stein
Journal:  Clin Rheumatol       Date:  2008-12-17       Impact factor: 2.980

10.  Antagonism of thromboxane receptors by diclofenac and lumiracoxib.

Authors:  E Selg; C Buccellati; M Andersson; G E Rovati; M Ezinga; A Sala; A-K Larsson; M Ambrosio; E Ambrosio; L Låstbom; V Capra; B Dahlén; A Ryrfeldt; G C Folco; S-E Dahlén
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.